NCT03526861 - Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6). | Biotech Hunter

Enrollment

301

Participants

Timeline

Start Date

June 19, 2018

Primary Completion Date

April 15, 2020

Study Completion Date

March 16, 2021

Conditions

Atopic Dermatitis

Interventions

DRUG

Tralokinumab

Tralokinumab is a human recombinant monoclonal antibody of the immunoglobulin G4 (IgG4) subclass that specifically binds to human interleukin (IL) 13 and blocks interaction with the IL-13 receptors.

DRUG

Placebos

Placebo contains the same excipients in the same concentration only lacking tralokinumab.

Trial Locations (87)

1200

Leo Pharma Investigationel Site, Brussels

2010

Leo Pharma Investigationel Site, Darlinghurst

2217

Leo Pharma Investigationel Site, Kogarah

3002

Leo Pharma Investigationel Site, Melbourne

3015

Leo Pharma Investigationel Site, Rotterdam

4000

Leo Pharma Investigationel Site, Liège

4102

Leo Pharma Investigationel Site, Woolloongabba

4708

Leo Pharma Investigationel Site, Bergen op Zoom

4818

Leo Pharma Investigationel Site, Breda

9713

Leo Pharma Investigationel Site, Groningen

9990

Leo Pharma Investigational Site, Maldegem

10075

Leo Pharma Investigational Site, New York

10115

Leo Pharma Investigationel Site, Berlin

13285

Leo Pharma Investigationel Site, Marseille

14830

LEO Pharma Investigational Site, Corning

19104

LEO Pharma Investigational Site, Philadelphia

26000

Leo Pharma Investigationel Site, Valence

27262

LEO Pharma Investigational Site, High Point

29420

Leo Pharma Investigational Site, North Charleston

31707

Leo Pharma Investigational Site, Albany

33137

LEO Pharma Investigational Site, Miami

35209

LEO Pharma Investigational Site, Birmingham

37130

Leo Pharma Investigational Site, Murfreesboro

40215

LEO Pharma Investigational Site, Louisville

43209

LEO Pharma Investigational Site, Bexley

48103

LEO Pharma Investigational Site, Ann Arbor

48197

LEO Pharma Investigational Site, Ypsilanti

49074

Leo Pharma Investigationel Site, Jena

Leo Pharma Investigationel Site, Osnabrück

55402

LEO Pharma Investigational Site, Minneapolis

60611

LEO Pharma Investigational Site, Chicago

70808

LEO Pharma Investigational Site, Baton Rouge

72916

LEO Pharma Investigational Site, Fort Smith

74136

Leo Pharma Investigational Site, Tulsa

75015

Leo Pharma Investigationel Site, Paris

75020

Leo Pharma Investigationel Site, Paris

77030

LEO Pharma Investigational Site, Houston

78218

Leo Pharma Investigational Site, San Antonio

78746

LEO Pharma Investigational Site, Austin

90045

LEO Pharma Investigational Site, Los Angeles

92708

Leo Pharma Investigational Site, Fountain Valley

94132

LEO Pharma Investigational Site, San Francisco

94304

LEO Pharma Investigational Site, Stanford

97223

LEO Pharma Investigational Site, Portland

97239

LEO Pharma Investigational Site, Portland

06520-8059

LEO Pharma Investigational Site, New Haven

08520

LEO Pharma Investigational Site, East Windsor

B-9000

Leo Pharma Investigationel Site, Ghent

T3A 2N1

LEO Pharma Investigational Site, Calgary

T6G 1C9

LEO Pharma Investigational Site, Edmonton

V3R 6A7

LEO Pharma Investigational Site, Surrey

R3C 1T6

LEO Pharma Investigational Site, Winnipeg

R3M 3Z4

LEO Pharma Investigational Site, Winnipeg

L3P 1X2

LEO Pharma Investigational Site, Markham

L6J 7W5

LEO Pharma Investigational Site, Oakville

M5A 3R6

LEO Pharma Investigational Site, Toronto

N8X 2G1

LEO Pharma Investigational Site, Windsor

H3T 1C5

LEO Pharma Investigational Site, Montreal

S7K 0H6

LEO Pharma Investigational Site, Saskatoon

06200

Leo Pharma Investigationel Site, Nice

01307

Leo Pharma Investigationel Site, Dresden

814-0180

Leo Pharma Investigationel Site, Fukuoka

890-8520

Leo Pharma Investigationel Site, Kagoshima

602-8566

Leo Pharma Investigationel Site, Kyoto

457-8510

Leo Pharma Investigationel Site, Nagoya

080-0013

Leo Pharma Investigationel Site, Obihiro

593-8324

Leo Pharma Investigationel Site, Osaka

560-0085

Leo Pharma Investigationel Site, Osaka-fu

329-0498

Leo Pharma Investigationel Site, Shimotsuke

136-0074

Leo Pharma Investigationel Site, Tokyo

141-8625

Leo Pharma Investigationel Site, Tokyo

169-0075

Leo Pharma Investigationel Site, Tokyo

171-0022

Leo Pharma Investigationel Site, Tokyo

514-8507

Leo Pharma Investigationel Site, Tsu

400-8506

Leo Pharma Investigationel Site, Yamanashi

30-033

Leo Pharma Investigationel Site, Krakow

30-149

Leo Pharma Investigationel Site, Krakow

31-011

Leo Pharma Investigationel Site, Krakow

90-265

Leo Pharma Investigationel Site, Lodz

90-436

Leo Pharma Investigationel Site, Lodz

35-055

Leo Pharma Investigationel Site, Rzeszów

21-040

Leo Pharma Investigationel Site, Świdnik

50-001

Leo Pharma Investigationel Site, Wroclaw

51-318

Leo Pharma Investigationel Site, Wroclaw

52-416

Leo Pharma Investigationel Site, Wroclaw

G51 4TF

Leo Pharma Investigationel Site, Glasgow

E11 1NR

Leo Pharma Investigationel Site, London